PMS2 and cancer: Based on current guidelines from the National Comprehensive Cancer Network (NCCN), the overall risk of developing LS-related cancers in individuals carrying a PMS2 PV/LPV is similar to that of the general population (NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric.